MIC:GEMA (Russia)
Â
Ordinary Shares
₽
131.70
(+1.39%)
Jan 3
Business Description
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC
ISIN : RU000A100GC7
Share Class Description:
MIC:GEMA: Ordinary SharesDescription
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.98 | |||||
| 9-Day RSI | 69.3 | |||||
| 14-Day RSI | 59.95 | |||||
| 6-1 Month Momentum % | -20.42 | |||||
| 12-1 Month Momentum % | -87.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 13.91 | |||||
| Dividend Payout Ratio | 0.58 | |||||
| Forward Dividend Yield % | 16.49 | |||||
| 5-Year Yield-on-Cost % | 13.91 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 160.57 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₽) | 139.365 | ||
| EPS (TTM) (₽) | 3.434 | ||
| Beta | 0 | ||
| Volatility % | 48.77 | ||
| 14-Day RSI | 59.95 | ||
| 14-Day ATR (₽) | 5.093939 | ||
| 20-Day SMA (₽) | 125.145 | ||
| 12-1 Month Momentum % | -87.53 | ||
| 52-Week Range (₽) | 118.8 - 1306.5 | ||
| Shares Outstanding (Mil) | 14.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Stock Events
| Event | Date | Price(₽) | ||
|---|---|---|---|---|
| No Event Data | ||||
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Frequently Asked Questions
What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC(MIC:GEMA)'s stock price today?
The current price of MIC:GEMA is ₽131.70. The 52 week high of MIC:GEMA is ₽1306.50 and 52 week low is ₽118.80.
When is next earnings date of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC(MIC:GEMA)?
The next earnings date of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC(MIC:GEMA) is 0.
Does Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC(MIC:GEMA) pay dividends? If so, how much?
The Dividend Yield %  of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC(MIC:GEMA) is 13.91% (As of Today), Highest Dividend Payout Ratio of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC(MIC:GEMA) was 0.58. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC(MIC:GEMA) is 16.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers